C26H35N3O4
Neat
453.58
-20°C
Room Temperature
868539-99-5; (alphaS)-alpha-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine methyl ester mono(trifluoroacetate); (S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate 2, 2, 2-trifluoroacetate; C28H36F3N3O6; L-Phenylalanine, (aS)-a-aminobenzenebutanoyl-L-leucyl-, methyl ester, mono(trifluoroacetate); methyl (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-phenylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoate;2, 2, 2-trifluoroacetic acid; (S)-methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate trifluoroacetate; (aS)-a-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine Methyl Ester Mono(trifluoroacetate); MFCD28387169; (S)-Methyl 2-((S)-2-((S)-2-aMino-4-phenylbutanaMido)-4-MethylpentanaMido)-3-phenylpropanoate trifluoroacetic acid; HY-I0749A; AKOS027339150; AC-29980; CS-15214; DA-59541; PD196189; CS-0010197; Carfilzomib Impurity 37 (Trifluoroacetic Acid); (aS)-a-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine Methyl Ester 2, 2, 2-Trifluoroacetate; (S)-Methyl2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate2, 2 and 2-trifluoroacetate
methyl (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-phenylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoate;2, 2 and 2-trifluoroacetic acid
InChI=1S/C26H35N3O4.C2HF3O2/c1-18(2)16-22(28-24(30)21(27)15-14-19-10-6-4-7-11-19)25(31)29-23(26(32)33-3)17-20-12-8-5-9-13-20;3-2(4,5)1(6)7/h4-13,18,21-23H,14-17,27H2,1-3H3,(H,28,30)(H,29,31);(H,6,7)/t21-,22-,23-;/m0./s1